Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose hypertension is either uncontrolled by or resistant to existing medicines.

OMRON and Tricog plan to expand KeeboHealth widely across India in 2025, marking a paradigm shift in remote cardiac care. The combined expertise of both organisations promises a scalable, ...

The band can be worn during the day and night, allowing patients to track blood pressure patterns across a 24-hour cycle.

AstraZeneca Plc’s experimental hypertension drug Baxdrostat reduced the blood pressure of patients who have an uncontrolled ...

High blood pressure is known as the 'silent killer' as it often doesn't cause any symptoms, but there are a few subtle ...